Oxygen uptake and carbon dioxide elimination after acetazolamide in the critically ill.
Acetazolamide, which reversibly inhibits carbonic anhydrase, is a useful diuretic in alkalotic and over-hydrated patients. In two earlier investigations we have consistently found increases in the arterial and venous oxygen saturation and tension when patients were treated with acetazolamide 15 mg . kg-1. A plausible explanation of this phenomenon is that acetazolamide diminishes oxygen consumption. In the present study we measured oxygen uptake in 10 critically ill patients. We found a minor and statistically insignificant decrease in oxygen consumption. Nevertheless SVO2 increased from 0.77 to 0.83 and PVO2 from 5.9 kPa to 6.8 kPa. It is still not possible from this investigation to determine the origin of the improvement in blood oxygenation. The inhibition of carbonic anhydrase caused a CO2 retention of 5.8% of the total CO2 production. An increase in body stores of CO2 of this magnitude is without clinical significance.
D000086:Acetazolamide / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000471:Alkalosis / Q000517:prevention & control; D002245:Carbon Dioxide / Q000032:analysis* / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects*
D002245:Carbon Dioxide; D000086:Acetazolamide; D010100:Oxygen